1 Market Overview of Targeted Drug MEK Inhibitors for NSCLC 1.1 Targeted Drug MEK Inhibitors for NSCLC Market Overview 1.1.1 Targeted Drug MEK Inhibitors for NSCLC Product Scope 1.1.2 Targeted Drug MEK Inhibitors for NSCLC Market Status and Outlook 1.2 Global Targeted Drug MEK Inhibitors for NSCLC Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Targeted Drug MEK Inhibitors for NSCLC Market Size by Region (2016-2027) 1.4 Global Targeted Drug MEK Inhibitors for NSCLC Historic Market Size by Region (2016-2021) 1.5 Global Targeted Drug MEK Inhibitors for NSCLC Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) 1.6.1 North America Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) 1.6.2 Europe Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) 1.6.3 Asia-Pacific Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) 1.6.4 Latin America Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) 1.6.5 Middle East & Africa Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) 2 Targeted Drug MEK Inhibitors for NSCLC Market Overview by Type 2.1 Global Targeted Drug MEK Inhibitors for NSCLC Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Targeted Drug MEK Inhibitors for NSCLC Historic Market Size by Type (2016-2021) 2.3 Global Targeted Drug MEK Inhibitors for NSCLC Forecasted Market Size by Type (2022-2027) 2.4 Trametinib 2.5 Other 3 Targeted Drug MEK Inhibitors for NSCLC Market Overview by Application 3.1 Global Targeted Drug MEK Inhibitors for NSCLC Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Targeted Drug MEK Inhibitors for NSCLC Historic Market Size by Application (2016-2021) 3.3 Global Targeted Drug MEK Inhibitors for NSCLC Forecasted Market Size by Application (2022-2027) 3.4 Squamous Cell Carcinoma of NSCLC 3.5 Adenocarcinoma of NSCLC 3.6 Large Cell Carcinoma of NSCLC 4 Targeted Drug MEK Inhibitors for NSCLC Competition Analysis by Players 4.1 Global Targeted Drug MEK Inhibitors for NSCLC Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Targeted Drug MEK Inhibitors for NSCLC as of 2020) 4.3 Date of Key Players Enter into Targeted Drug MEK Inhibitors for NSCLC Market 4.4 Global Top Players Targeted Drug MEK Inhibitors for NSCLC Headquarters and Area Served 4.5 Key Players Targeted Drug MEK Inhibitors for NSCLC Product Solution and Service 4.6 Competitive Status 4.6.1 Targeted Drug MEK Inhibitors for NSCLC Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Novartis 5.1.1 Novartis Profile 5.1.2 Novartis Main Business 5.1.3 Novartis Targeted Drug MEK Inhibitors for NSCLC Products, Services and Solutions 5.1.4 Novartis Targeted Drug MEK Inhibitors for NSCLC Revenue (US$ Million) & (2016-2021) 5.1.5 Novartis Recent Developments ... 6 North America 6.1 North America Targeted Drug MEK Inhibitors for NSCLC Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Targeted Drug MEK Inhibitors for NSCLC Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Targeted Drug MEK Inhibitors for NSCLC Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Targeted Drug MEK Inhibitors for NSCLC Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Targeted Drug MEK Inhibitors for NSCLC Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Targeted Drug MEK Inhibitors for NSCLC Market Dynamics 11.1 Targeted Drug MEK Inhibitors for NSCLC Industry Trends 11.2 Targeted Drug MEK Inhibitors for NSCLC Market Drivers 11.3 Targeted Drug MEK Inhibitors for NSCLC Market Challenges 11.4 Targeted Drug MEK Inhibitors for NSCLC Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Targeted Drug MEK Inhibitors for NSCLC Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Targeted Drug MEK Inhibitors for NSCLC Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Targeted Drug MEK Inhibitors for NSCLC Market Size Share by Region (2016-2021) Table 4. Global Targeted Drug MEK Inhibitors for NSCLC Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Targeted Drug MEK Inhibitors for NSCLC Forecasted Market Size Share by Region (2022-2027) Table 6. Global Targeted Drug MEK Inhibitors for NSCLC Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Targeted Drug MEK Inhibitors for NSCLC Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Targeted Drug MEK Inhibitors for NSCLC Revenue Market Share by Type (2016-2021) Table 9. Global Targeted Drug MEK Inhibitors for NSCLC Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Targeted Drug MEK Inhibitors for NSCLC Revenue Market Share by Type (2022-2027) Table 11. Global Targeted Drug MEK Inhibitors for NSCLC Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Targeted Drug MEK Inhibitors for NSCLC Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Targeted Drug MEK Inhibitors for NSCLC Revenue Market Share by Application (2016-2021) Table 14. Global Targeted Drug MEK Inhibitors for NSCLC Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Targeted Drug MEK Inhibitors for NSCLC Revenue Market Share by Application (2022-2027) Table 16. Global Targeted Drug MEK Inhibitors for NSCLC Revenue (US$ Million) by Players (2016-2021) Table 17. Global Targeted Drug MEK Inhibitors for NSCLC Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Targeted Drug MEK Inhibitors for NSCLC as of 2020) Table 19. Date of Key Manufacturers Enter into Targeted Drug MEK Inhibitors for NSCLC Market Table 20. Global Targeted Drug MEK Inhibitors for NSCLC Top Players Headquarters and Area Served Table 21. Targeted Drug MEK Inhibitors for NSCLC Product Solution and Service Table 22. Global Targeted Drug MEK Inhibitors for NSCLC Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Novartis Basic Information List Table 25. Novartis Description and Business Overview Table 26. Novartis Targeted Drug MEK Inhibitors for NSCLC Products, Services and Solutions Table 27. Revenue (US$ Million) in Targeted Drug MEK Inhibitors for NSCLC Business of Novartis (2016-2021) Table 28. Novartis Recent Developments Table 29. North America Targeted Drug MEK Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million) Table 30. North America Targeted Drug MEK Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 31. Europe Targeted Drug MEK Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million) Table 32. Europe Targeted Drug MEK Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 33. Asia-Pacific Targeted Drug MEK Inhibitors for NSCLC Market Size by Region (2016-2021) & (US$ Million) Table 34. Asia-Pacific Targeted Drug MEK Inhibitors for NSCLC Market Size by Region (2022-2027) & (US$ Million) Table 35. Asia-Pacific Targeted Drug MEK Inhibitors for NSCLC Market Share by Region (2016-2021) Table 36. Asia-Pacific Targeted Drug MEK Inhibitors for NSCLC Market Share by Region (2022-2027) Table 37. Latin America Targeted Drug MEK Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million) Table 38. Latin America Targeted Drug MEK Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 39. Middle East & Africa Targeted Drug MEK Inhibitors for NSCLC Market Size by Players (2016-2021) & (US$ Million) Table 40. Middle East & Africa Targeted Drug MEK Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 41. Targeted Drug MEK Inhibitors for NSCLC Market Trends Table 42. Targeted Drug MEK Inhibitors for NSCLC Market Drivers Table 43. Targeted Drug MEK Inhibitors for NSCLC Market Challenges Table 44. Targeted Drug MEK Inhibitors for NSCLC Market Restraints Table 45. Research Programs/Design for This Report Table 46. Key Data Information from Secondary Sources Table 47. Key Data Information from Primary Sources List of Figures Figure 1. Global Targeted Drug MEK Inhibitors for NSCLC Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Targeted Drug MEK Inhibitors for NSCLC Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Targeted Drug MEK Inhibitors for NSCLC Market Share by Regions: 2021 VS 2027 Figure 4. Global Targeted Drug MEK Inhibitors for NSCLC Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Targeted Drug MEK Inhibitors for NSCLC Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Targeted Drug MEK Inhibitors for NSCLC Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Targeted Drug MEK Inhibitors for NSCLC Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Targeted Drug MEK Inhibitors for NSCLC Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Targeted Drug MEK Inhibitors for NSCLC Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Targeted Drug MEK Inhibitors for NSCLC Market Size Share by Type in 2021 & 2027 Figure 11. Trametinib Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Other Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Global Targeted Drug MEK Inhibitors for NSCLC Market Size Share by Application in 2021 & 2027 Figure 14. Squamous Cell Carcinoma of NSCLC Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Adenocarcinoma of NSCLC Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Large Cell Carcinoma of NSCLC Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Targeted Drug MEK Inhibitors for NSCLC Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 18. Global Top 5 and Top 10 Players Targeted Drug MEK Inhibitors for NSCLC Market Share in 2020 Figure 19. North America Targeted Drug MEK Inhibitors for NSCLC Market Share by Country (2016-2027) Figure 20. United States Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 21. Canada Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 22. Germany Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 23. France Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 24. U.K. Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 25. Italy Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 26. Russia Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 27. Nordic Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 28. Rest of Europe Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 29. Asia-Pacific Targeted Drug MEK Inhibitors for NSCLC Market Share by Region (2016-2027) Figure 30. China Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 31. Japan Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 32. South Korea Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 33. Southeast Asia Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 34. India Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 35. Australia Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 36. Rest of Asia-Pacific Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 37. Latin America Targeted Drug MEK Inhibitors for NSCLC Market Share by Country (2016-2027) Figure 38. Mexico Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 39. Brazil Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 40. Rest of Latin America Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 41. Middle East & Africa Targeted Drug MEK Inhibitors for NSCLC Market Share by Country (2016-2027) Figure 42. Turkey Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 43. Saudi Arabia Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 44. UAE Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 45. Rest of Middle East & Africa Targeted Drug MEK Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 46. Bottom-up and Top-down Approaches for This Report Figure 47. Data Triangulation

Novartis